Format

Send to

Choose Destination
See comment in PubMed Commons below
Epigenetics. 2013 Aug;8(8):802-6. doi: 10.4161/epi.25501. Epub 2013 Jun 28.

SNPs located at CpG sites modulate genome-epigenome interaction.

Author information

  • 1Department of Biostatistics; University of Alabama; Birmingham, AL USA.

Abstract

DNA methylation is an important molecular-level phenotype that links genotypes and complex disease traits. Previous studies have found local correlation between genetic variants and DNA methylation levels (cis-meQTLs). However, general mechanisms underlying cis-meQTLs are unclear. We conducted a cis-meQTL analysis of the Genetics of Lipid Lowering Drugs and Diet Network data (n = 593). We found that over 80% of genetic variants at CpG sites (meSNPs) are meQTL loci (P-value<10(-9)), and meSNPs account for over two thirds of the strongest meQTL signals (P-value<10(-200)). Beyond direct effects on the methylation of the meSNP site, the CpG-disrupting allele of meSNPs were associated with lowered methylation of CpG sites located within 45 bp. The effect of meSNPs extends to as far as 10 kb and can contribute to the observed meQTL signals in the surrounding region, likely through correlated methylation patterns and linkage disequilibrium. Therefore, meSNPs are behind a large portion of observed meQTL signals and play a crucial role in the biological process linking genetic variation to epigenetic changes.

KEYWORDS:

DNA methylation; Infinium Human Methylation 450K BeadChip; epigenome-wide study; meQTL; meSNP

PMID:
23811543
PMCID:
PMC3883783
DOI:
10.4161/epi.25501
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center